Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Protara Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Biological Products, (No Diagnostic Substances)
No intraday reading yet this session.
120 institutional managers report a position in Protara Therapeutics, Inc. worth $176.1M between them, filed on form 13F for the quarter ending 2026-06-30. 21 of them hold 80% of it, the largest being Jupiter Topco LLC at 10.18%.
95 more managers in the register
21 managers hold 80% of the $176.1M institutional base. The other 99 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
TARA (Protara Therapeutics, Inc.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
via Jupiter Topco LLC, Orbimed Advisors LLC, Marshall Wace LLP +6 more · 10.18% of TARA, 11.12% of RLMD
via Jupiter Topco LLC, Orbimed Advisors LLC, Balyasny Asset Management LLC +1 more · 10.18% of TARA, 21.12% of MNPR
via Jupiter Topco LLC, Balyasny Asset Management LLC, ADAR1 Capital Management, LLC +3 more · 10.18% of TARA, 14.11% of OVID
via Jupiter Topco LLC, Orbimed Advisors LLC, Balyasny Asset Management LLC +3 more · 10.18% of TARA, 4.48% of LXEO
via Jupiter Topco LLC, 5AM Venture Management, LLC, Balyasny Asset Management LLC · 10.18% of TARA, 15.14% of CAMP
via Jupiter Topco LLC, Velan Capital Investment Management LP, Marshall Wace LLP +3 more · 10.18% of TARA, 17.36% of IMMX
Managers holding a meaningful stake in TARA also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.